Submissions from 2024
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
Treatment and Outcomes of 4,973 Unicameral Bone Cysts: A Systematic Review and Meta-Analysis, Juan Pretell
Trials and Technology to Advance Upper Gastrointestinal Oncology: Imagination, Imaging, and the Intertwined Imperfections, Michael Chuong
Update on Oral and Oropharyngeal Cancers: A guide for oral health care providers, Alessandro Villa
Use of Imiquimod 5% cream for the treatment of lentigo maligna on the face, Laura Benitez, Uzma Farooq, and Naiara Braghiroli
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904), Ana Sandoval-Leon
Vitiligo-like amelanotic melanoma in situ: A rare presentation, Uzma Farooq and Naiara Braghiroli
Submissions from 2023
Irreversible electroporation as a focal therapy for localized prostate cancer: A systematic review, Pushan Prabhakar, Arjun Pon Avudaiappan, Ahmed Eldefrawy, Jorge Caso, Govindarajan Narayanan, and Murugesan Manoharan
Risk Factors and Management of Prosthetic Joint Infections in Megaprostheses-A Review of the Literature, Juan Pretell
The First Report of Using Low-Field MRI-Guided Radiation Therapy in a Patient With a Cochlear Implant, James McCulloch, Nema Bassiri Gharb, Alonso Gutierrez, Jennifer Armas, Kevin Abrams, Minesh Mehta, Michael Chuong, and Kathryn Mittauer
Racial difference in mortality among COVID-19 hospitalizations in California, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Juan Zevallos, Md Ashfaq Ahmed, Zhenwei Zhang, Peter McGranaghan, Sandra Chaparro, and Javier Jimenez
DUSP22-IRF4 Rearranged CD30-Positive Primary Cutaneous Lymphoproliferative Disorder With Gamma/Delta Phenotype, Yuliya Linhares
Evaluating a Novel Patient Intake Model for Newly Referred Patients Seeking Cancer Care: An Evidence-Based Practice Project, Roquinna Serna, Stella Fernandez, Morgan Nestingen, and Stephen Breazeale
Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: a Critical and Updated Review of the Literature, Domenech Asbun, Ramon Jimenez, and Horacio Asbun
Management of Brain Metastases: A Review of Novel Therapies, Shreyas Bellur, Atulya Khosla, Rupesh Kotecha, Michael McDermott, and Manmeet Ahluwalia
Tumor treating fields: narrative review of a promising treatment modality for cancer, Tugce Kutuk, Alonso La Rosa De Los Rios, Rupesh Kotecha, Minesh Mehta, and Michael Chuong
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults, Minesh Mehta
A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer, Kathryn Mittauer and Michael Chuong
CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Ahmad Ozair, Atulya Khosla, Shreyas Bellur, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Cristina Sandoval Leon, and Reshma Mahtani
CTNI-21: Phase I Study of BTK Inhibitor Ibrutinib with Temozolomide and Radiation in Newly-diagnosed Glioblastoma (EQUILIBRIUM): Final Trial Report, Manmeet Ahluwalia, Ahmad Ozair, and Atulya Khosla